TU Dresden

Advances in Alzheimer’s research by Dr. Caghan Kizil and his research group
The research team of Dr. Caghan Kizil achieved a major advance in Alzheimer’s research. They showed how a diseased vertebrate brain can naturally react to Alzheimer’s pathology by forming more... [read more]
© Kizil Lab / CRTD
Paradigm shift in the research field of photoreceptor transplantation: mechanism improving the function of the retina works different than previously assumed
Research group of Prof. Dr. Marius Ader introduces a new understanding of the mechanism of cell transplantations that aim to improve retinal function. [read more]
Insights into research: visit of pupils was a great success
A group of pupils from Gymnasium Luisenstift Radebeul visited the CRTD and got to know the research conducted here and the courses of study offered by CRTD/BIOTEC. [read more]
Insights into science: DFG-Center CRTD offers 3 Voluntary Social Year places
The DFG-Center for Regenerative Therapies Dresden (CRTD), Cluster of Excellence at TU Dresden, provides the possibility for a Voluntary Social Year (Freiwilliges Soziales Jahr, “FSJ”) in science for... [read more]

At the DFG-Center for Regenerative Therapies Dresden (CRTD), our mission is to understand the biology of stem cells and physiological and pathological tissue and organ repair in order to develop new treatments for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, haematological diseases, such as leukemia, metabolic diseases, such as diabetes, and bone diseases. Our scientists are encouraged to think outside the box and to explore untapped areas of knowledge in the regenerative potential of the human body, and to apply this knowledge to prevent or reverse disease processes.

To achieve our aims, we strongly support interdisciplinary research, with eighteen core groups in a network of 87 principal investigators from diverse research institutes on the Dresden campus, with expertise in everything from the biology of cells and tissues to biomaterials to nanoengineering. CRTD has become a major driving force on campus and is ready to meet the challenges of moving new interventional strategies from bench to bedside.